Advertisement
Review Article| Volume 34, ISSUE 1, P99-111, March 2014

Download started.

Ok

Cardiac Markers Following Cardiac Surgery and Percutaneous Coronary Intervention

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Jaffe A.S.
        • Babuin L.
        • Apple F.S.
        Biomarkers in acute cardiac disease: the present and the future.
        J Am Coll Cardiol. 2006; 48: 1-11
        • Thygesen K.
        • Alpert J.S.
        • Jaffe A.S.
        • et al.
        Third universal definition of myocardial infarction.
        Eur Heart J. 2012; 33: 2551-2567
        • Miller W.L.
        • Garratt K.N.
        • Burritt M.F.
        • et al.
        Baseline troponin level: key to understanding the importance of post-PCI troponin elevations.
        Eur Heart J. 2006; 27: 1061-1069
      1. Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization task force on standardization of clinical nomenclature.
        Circulation. 1979; 59: 607-609
        • Jaffe A.S.
        • Garfinkel B.T.
        • Ritter C.S.
        • et al.
        Plasma MB creatine kinase after vigorous exercise in professional athletes.
        Am J Cardiol. 1984; 53: 856-858
        • Schwartz J.G.
        • Prihoda T.J.
        • Stuckey J.H.
        • et al.
        Creatine kinase MB in cases of skeletal muscle trauma.
        Clin Chem. 1988; 34: 898-901
        • Alpert J.S.
        • Thygesen K.
        • Antman E.
        • et al.
        Myocardial infarction redefined–a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.
        J Am Coll Cardiol. 2000; 36: 959-969
        • Thygesen K.
        • Alpert J.S.
        • White H.D.
        • et al.
        Universal definition of myocardial infarction.
        J Am Coll Cardiol. 2007; 50: 2173-2195
        • Herrmann J.
        Peri-procedural myocardial injury: 2005 update.
        Eur Heart J. 2005; 26: 2493-2519
        • Califf R.M.
        • Abdelmeguid A.E.
        • Kuntz R.E.
        • et al.
        Myonecrosis after revascularization procedures.
        J Am Coll Cardiol. 1998; 31: 241-251
        • Ellis S.G.
        • Chew D.
        • Chan A.
        • et al.
        Death following creatine kinase-MB elevation after coronary intervention: identification of an early risk period: importance of creatine kinase-MB level, completeness of revascularization, ventricular function, and probable benefit of statin therapy.
        Circulation. 2002; 106: 1205-1210
        • Kini A.
        • Marmur J.D.
        • Kini S.
        • et al.
        Creatine kinase-MB elevation after coronary intervention correlates with diffuse atherosclerosis, and low-to-medium level elevation has a benign clinical course: implications for early discharge after coronary intervention.
        J Am Coll Cardiol. 1999; 34: 663-671
        • Stone G.W.
        • Mehran R.
        • Dangas G.
        • et al.
        Differential impact on survival of electrocardiographic Q-wave versus enzymatic myocardial infarction after percutaneous intervention: a device-specific analysis of 7147 patients.
        Circulation. 2001; 104: 642-647
        • Saucedo J.F.
        • Mehran R.
        • Dangas G.
        • et al.
        Long-term clinical events following creatine kinase–myocardial band isoenzyme elevation after successful coronary stenting.
        J Am Coll Cardiol. 2000; 35: 1134-1141
        • Kong T.Q.
        • Davidson C.J.
        • Meyers S.N.
        • et al.
        Prognostic implication of creatine kinase elevation following elective coronary artery interventions.
        JAMA. 1997; 277: 461-466
        • Abdelmeguid A.E.
        • Topol E.J.
        • Whitlow P.L.
        • et al.
        Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions.
        Circulation. 1996; 94: 1528-1536
        • Novack V.
        • Pencina M.
        • Cohen D.J.
        • et al.
        Troponin criteria for myocardial infarction after percutaneous coronary intervention.
        Arch Intern Med. 2012; 172: 502-508
        • Kugelmass A.D.
        • Cohen D.J.
        • Moscucci M.
        • et al.
        Elevation of the creatine kinase myocardial isoform following otherwise successful directional coronary atherectomy and stenting.
        Am J Cardiol. 1994; 74: 748-754
        • Tricoci P.
        • Leonardi S.
        • White J.
        • et al.
        Cardiac troponin after percutaneous coronary intervention and 1-year mortality in non-ST-segment elevation acute coronary syndrome using systematic evaluation of biomarker trends.
        J Am Coll Cardiol. 2013; 62: 242-251
        • Giannitsis E.
        • Kurz K.
        • Hallermayer K.
        • et al.
        Analytical validation of a high-sensitivity cardiac troponin T assay.
        Clin Chem. 2010; 56: 254-261
        • Bonaca M.P.
        • Wiviott S.D.
        • Braunwald E.
        • et al.
        American College of Cardiology/American Heart Association/European Society of Cardiology/World Heart Federation universal definition of myocardial infarction classification system and the risk of cardiovascular death: observations from the TRITON-TIMI 38 trial (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis in Myocardial Infarction 38).
        Circulation. 2012; 125: 577-583
        • Stone G.W.
        • Ware J.H.
        • Bertrand M.E.
        • et al.
        Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: one-year results from the ACUITY trial.
        JAMA. 2007; 298: 2497-2506
        • Cavallini C.
        • Verdecchia P.
        • Savonitto S.
        • et al.
        Prognostic value of isolated troponin I elevation after percutaneous coronary intervention.
        Circ Cardiovasc Interv. 2010; 3: 431-435
        • Feldman D.N.
        • Kim L.
        • Rene A.G.
        • et al.
        Prognostic value of cardiac troponin-I or troponin-T elevation following nonemergent percutaneous coronary intervention: a meta-analysis.
        Catheter Cardiovasc Interv. 2011; 77: 1020-1030
        • Cutlip D.E.
        • Windecker S.
        • Mehran R.
        • et al.
        Clinical end points in coronary stent trials: a case for standardized definitions.
        Circulation. 2007; 115: 2344-2351
        • Conti C.R.
        • Mehta J.L.
        Acute myocardial ischemia: role of atherosclerosis, thrombosis, platelet activation, coronary vasospasm, and altered arachidonic acid metabolism.
        Circulation. 1987; 75: V84-V95
        • Adams M.R.
        • Kinlay S.
        • Blake G.J.
        • et al.
        Pathophysiology of atherosclerosis: development, regression, restenosis.
        Curr Atheroscler Rep. 2000; 2: 251-258
        • Farb A.
        • Sangiorgi G.
        • Carter A.J.
        • et al.
        Pathology of acute and chronic coronary stenting in humans.
        Circulation. 1999; 99: 44-52
        • Lemson M.S.
        • Tordoir J.H.
        • Daemen M.J.
        • et al.
        Intimal hyperplasia in vascular grafts.
        Eur J Vasc Endovasc Surg. 2000; 19: 336-350
        • Stary H.C.
        • Blankenhorn D.H.
        • Chandler A.B.
        • et al.
        A definition of the intima of human arteries and of its atherosclerosis-prone regions. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association.
        Arterioscler Thromb. 1992; 12: 120-134
        • Kulik A.
        • Le May M.R.
        • Voisine P.
        • et al.
        Aspirin plus clopidogrel versus aspirin alone after coronary artery bypass grafting: the Clopidogrel After Surgery for Coronary Artery Disease (CASCADE) Trial.
        Circulation. 2010; 122: 2680-2687
        • McFadden E.P.
        • Stabile E.
        • Regar E.
        • et al.
        Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy.
        Lancet. 2004; 364: 1519-1521
        • Benoit M.O.
        • Paris M.
        • Silleran J.
        • et al.
        Cardiac troponin I: its contribution to the diagnosis of perioperative myocardial infarction and various complications of cardiac surgery.
        Crit Care Med. 2001; 29: 1880-1886
        • Kovacevic R.
        • Majkic-Singh N.
        • Ignjatovic S.
        • et al.
        Troponin T levels in detection of perioperative myocardial infarction after coronary artery bypass surgery.
        Clin Lab. 2004; 50: 437-445
        • Noora J.
        • Ricci C.
        • Hastings D.
        • et al.
        Determination of troponin I release after CABG surgery.
        J Card Surg. 2005; 20: 129-135
        • Klatte K.
        • Chaitman B.R.
        • Theroux P.
        • et al.
        Increased mortality after coronary artery bypass graft surgery is associated with increased levels of postoperative creatine kinase-myocardial band isoenzyme release: results from the GUARDIAN trial.
        J Am Coll Cardiol. 2001; 38: 1070-1077
        • Brener S.J.
        • Lytle B.W.
        • Schneider J.P.
        • et al.
        Association between CK-MB elevation after percutaneous or surgical revascularization and three-year mortality.
        J Am Coll Cardiol. 2002; 40: 1961-1967
        • Bignami E.
        • Landoni G.
        • Crescenzi G.
        • et al.
        Role of cardiac biomarkers (troponin I and CK-MB) as predictors of quality of life and long-term outcome after cardiac surgery.
        Ann Card Anaesth. 2009; 12: 22-26
        • Januzzi J.L.
        • Lewandrowski K.
        • MacGillivray T.E.
        • et al.
        A comparison of cardiac troponin T and creatine kinase-MB for patient evaluation after cardiac surgery.
        J Am Coll Cardiol. 2002; 39: 1518-1523
        • Thielmann M.
        • Massoudy P.
        • Marggraf G.
        • et al.
        Role of troponin I, myoglobin, and creatine for the detection of early graft failure following coronary artery bypass grafting.
        Eur J Cardiothorac Surg. 2004; 26: 102-109
        • Mohammed A.A.
        • Agnihotri A.K.
        • van Kimmenade R.R.
        • et al.
        Prospective, comprehensive assessment of cardiac troponin T testing after coronary artery bypass graft surgery.
        Circulation. 2009; 120: 843-850
        • Nesher N.
        • Alghamdi A.A.
        • Singh S.K.
        • et al.
        Troponin after cardiac surgery: a predictor or a phenomenon?.
        Ann Thorac Surg. 2008; 85: 1348-1354
        • Göber V.
        • Hohl A.
        • Gahl B.
        • et al.
        Early troponin T and prediction of potentially correctable in-hospital complications after coronary artery bypass grafting surgery.
        PLoS One. 2013; 8: e74241
        • Selvanayagam J.B.
        • Pigott D.
        • Balacumaraswami L.
        • et al.
        Relationship of irreversible myocardial injury to troponin I and creatine kinase-MB elevation after coronary artery bypass surgery: insights from cardiovascular magnetic resonance imaging.
        J Am Coll Cardiol. 2005; 45: 629-631
        • Steuer J.
        • Bjerner T.
        • Duvernoy O.
        • et al.
        Visualisation and quantification of peri-operative myocardial infarction after coronary artery bypass surgery with contrast-enhanced magnetic resonance imaging.
        Eur Heart J. 2004; 25: 1293-1299
        • Van Lente F.
        • Martin A.
        • Ratliff N.B.
        • et al.
        The predictive value of serum enzymes for perioperative myocardial infarction after cardiac operations. An autopsy study.
        J Thorac Cardiovasc Surg. 1989; 98: 704-710
        • Radomski M.W.
        • Palmer R.M.
        • Moncada S.
        Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium.
        Lancet. 1987; 2: 1057-1058
        • Radomski M.W.
        • Palmer R.M.
        • Moncada S.
        The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide.
        Br J Pharmacol. 1987; 92: 639-646
        • Bennett-Guerrero E.
        • Zhao Y.
        • O'Brien S.M.
        • et al.
        Variation in use of blood transfusion in coronary artery bypass graft surgery.
        JAMA. 2010; 304: 1568-1575
        • Verrier E.D.
        • Boyle Jr., E.M.
        Endothelial cell injury in cardiovascular surgery.
        Ann Thorac Surg. 1996; 62: 915-922
        • Motwani J.G.
        • Topol E.J.
        Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention.
        Circulation. 1998; 97: 916-931
        • Yong Z.Y.
        • Wiegerinck E.M.
        • Boerlage-van Dijk K.
        • et al.
        Predictors and prognostic value of myocardial injury during transcatheter aortic valve implantation.
        Circ Cardiovasc Interv. 2012; 5: 415-423
        • Leon M.B.
        • Piazza N.
        • Nikolsky E.
        • et al.
        Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium.
        J Am Coll Cardiol. 2011; 57: 253-269